NYSECommunication ServicesInternet Content & InformationSnapshot 2026-07-07
Reading STUB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track STUB free→QuarterlyIQ Insights · STUB
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 6 valuation methods, at three horizons. Current price $13.69. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $14 STUB trades at 3.0× p/s — 2.5× the 1.2× p/s peer median. The market is re-rating it beyond its own range; our $10 fair value is low-confidence here. Analysts target $8.25–$12. Not investment advice.
$8.25 – $12.50 (median $8.75) · 5 analysts · as of 2026-06-10
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price sits about 33% above a flat-multiple fair value, while analysts forecast about 17% growth — ahead of our forecast. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2024-Q3, 2025-Q1, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $8.75 | — | — | Analyst | high |
| dcf fcfe | 12M | $10.11 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $12.08 | — | — | Hist. CAGR | high |
| Peer EV/Sales | 12M | $14.27 | 3.1 | 4.61 | TTM | high |
| Peer P/FCF | 12M | $10.98 | 12.9 | 0.85 | TTM | high |
| Peer P/S | 12M | $5.49 | 1.2 | 4.61 | TTM | high |
| Peer EV/Sales | 3Y | $23.09 | 3.1 | 7.48 | Analyst | medium |
| Peer P/S | 3Y | $8.91 | 1.2 | 7.48 | Analyst | medium |
| Peer EV/Sales | 5Y | $30.51 | 3.1 | 9.90 | Analyst | medium |
| Peer P/S | 5Y | $11.79 | 1.2 | 9.90 | Analyst | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
